Navigation Links
Elsevier / MEDai Appoints Tom Zajac as New President

ORLANDO, Florida, November 28, 2011 /PRNewswire/ --

Elsevier / MEDai, the leader in predictive clinical analytic solutions, today announced that Thomas H. Zajac has been named the company's new President.  Elsevier / MEDai provides solutions for providers, health plans and  healthcare organizations focused on population management, physician profiling, regulatory compliance and clinical surveillance to improve healthcare outcomes.   

Elsevier / MEDai began with one simple idea: to help healthcare organizations transform volumes of clinical data into actionable insight, enabling better decisions and improving the quality, cost and effectiveness of the care process. Tom brings over 25 years experience in building clinical, financial, and operational performance improvement solutions for both vendor and healthcare organizations that provides a tremendous opportunity to energize the growth and vision of Elsevier / MEDai. 

"Tom's appointment comes at an important time as payers and providers are looking more to analytics to pull insights out of data to drive population management and physician performance programs", said Michael Hansen, CEO of Elsevier Health Sciences.  "Under his leadership MEDai will continue to help empower customers to make sound clinical and financial decisions that reduce risk, lower costs and improve the quality of care."

Tom was formerly President of CareScience, spending eight years building the company into one of the leading providers of integrated quality improvement, regulatory reporting, outcomes research, HIE data exchange, and transformational services to over 250 health organizations. Prior to CareScience, Tom spent eleven years building Transition Systems' (TSI) success as the leader in healthcare decision support, with 1200 US and international provider and payer customers. TSI was acquired by Eclipsys, where Tom established and became President of the Business Solutions Division, providing advisory and transformation consulting to customers across its spectrum of products.

"MEDai is in a unique position to impact the healthcare process, with our award winning clinical analytics, process knowledge, and clinical insight," said Tom. "Our role as a true partner is to provide our customers with product and service solutions that both support their current needs and expands to support the industry's evolution to true population health and longitudinal care."  

Tom is a Senior Scholar with the Jefferson University School of Public Health, is a prior contributor to the Center for Healthcare Transformation, and has presented at both national and international forums on healthcare management. Most recently, Tom was Managing Director of Zajac and Associates, LLC, providing product and strategy services to private equity, vendor and provider customers in healthcare.

About Elsevier / MEDai

Elsevier / MEDai, Inc. is a leading health information company offering award-winning solutions for the improvement of healthcare delivery. Utilizing cutting-edge technology, payers and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time, and improve outcomes. For more information on Elsevier / MEDai, visit Its parent company, Elsevier (, is a world-leading provider of scientific, technical and medical information products and services, with more than 7,000 employees in over 70 offices across 24 countries.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Tom Reller
Vice President Global Corporate Relations, Elsevier

SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Elseviers PharmaPendium(TM) Adds European Medicines Agency (EMEA) Documents
2. Elsevier and the Association of Southeast Asian Institutions
3. Elseviers Partners With QUOSA
4. Elsevier Announces Winners of 3rd Annual Scopus Young Indian Scientist Award
5. Elsevier Introduces The American Journal of Medicine Blog
6. Elsevier Introduces Breakthrough Technology Intelligence Solution for Accelerating R&D and Innovation in Europe
7. The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books
8. Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy
9. Elsevier Launches Ten New eBook Specialty Collections on MD Consult
10. Elsevier Health Sciences Appoints Dr. David Goldmann Editor-in-Chief of its First Consult Point of Care Resource
11. Statement From Michael Hansen, CEO of Elseviers Health Sciences Division, Regarding Australia Based Sponsored Journal Practices Between 2000 and 2005
Post Your Comments:
(Date:11/30/2015)... -- Northwest Biotherapeutics (NASDAQ: NWBO ) ("NW Bio"), a ... solid tumor cancers, announced today that the Board is ... Company welcomes Neil Woodford,s call for an ... report on NW Bio.  The Company,s Board is under ... stated, "We agree with Mr. Woodford that, at NW ...
(Date:11/27/2015)... Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... that it has closed the sale of its global ... (GBT- NYSE Euronext) in a transaction valued at approximately ... facilities and a total of approximately 1,000 employees spread ... St. Louis area. This entire workforce ...
(Date:11/26/2015)... , November 26, 2015 ... device company specializing in imaging technologies, announced today that it ... as part of the Horizon 2020 European Union Framework Programme ... a large-scale clinical trial in breast cancer. , ... , --> --> The ...
(Date:11/25/2015)... Studies reveal the differences in species of ... way for more effective treatment for one of the most ... --> --> Gum disease is ... yet relatively little was understood about the bacteria associated with ... by researchers from the WALTHAM Centre for Pet Nutrition together ...
Breaking Biology Technology:
(Date:10/29/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that it has been selected ... of only three finalists for a 2015 Tekne ... category. The Tekne Awards honor Minnesota ... and leadership. iMedNet™ eClinical  technology ...
(Date:10/29/2015)... , Oct. 29, 2015 Daon, a global ... it has released a new version of its ... North America have already installed ... also includes a FIDO UAF certified server component ... preparing to activate FIDO features. These customers include some ...
(Date:10/29/2015)...  Connected health pioneer, Joseph C. Kvedar , ... health and wellness, and the business opportunities that arise ... Internet of Healthy Things . Long before health ... Dr. Kvedar, vice president, Connected Health, Partners HealthCare, was ... care from the hospital or doctor,s office into the ...
Breaking Biology News(10 mins):